Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach. Regulation and Deregulation of Industry, Schizophrenia, Therapy and Rehabilitation, Drugs (Pharmaceuticals), Psychology and Psychologists, Clinical Trials, Weight, Dopamine, Psychiatry and Psychiatrists, Research, Bristol Myers Squibb Company, Food and Drug Administration, Karuna Therapeutics Inc Read More
F.D.A. Approves a New Antipsychotic Drug
